Fortress Biotech Announces Eric Rowinsky’s Board Departure

Fortress Biotech (FBIO) has released an update to notify the public and investors about its officers.

Eric Rowinsky, M.D. has announced that he will not seek re-election to the Board of Directors of Fortress Biotech, Inc. at the 2024 Annual Meeting, due to other professional commitments. His tenure on the Board will conclude on the date of the meeting, and his decision was not because of any disagreement with the company’s operations, policies, or practices. Post-departure, the company plans to retain Dr. Rowinsky as a consultant.

For further insights into FBIO corporate activity, check out TipRanks’ Insiders Trading Activity page.